Antihistamine-resistant  urticaria factitia  successfully treated  with anti-immunoglobulin  E therapy.
Krause
K
K
Department of Dermatology and Allergy, Allergie-Centrum-Charité, Charité – Universitätsmedizin Berlin, Charitéplatz 1, D-10117 Berlin, Germany.
Ardelean
E
E
Kessler
B
B
Magerl
M
M
Metz
M
M
Siebenhaar
F
F
Weller
K
K
Worm
M
M
Zuberbier
T
T
Maurer
M
M
D018926:Anti-Allergic Agents / Q000627:therapeutic use; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D005260:Female; D006633:Histamine Antagonists / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E; D008875:Middle Aged; D000069444:Omalizumab; D014581:Urticaria / Q000188:drug therapy*
D018926:Anti-Allergic Agents; D000888:Antibodies, Anti-Idiotypic; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D006633:Histamine Antagonists; D000069444:Omalizumab; D007073:Immunoglobulin E